ES2053780T3 - Nuevos derivados 17-aza de 20,21-dinoreburnamenina y nuevos productos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen. - Google Patents

Nuevos derivados 17-aza de 20,21-dinoreburnamenina y nuevos productos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen.

Info

Publication number
ES2053780T3
ES2053780T3 ES88400901T ES88400901T ES2053780T3 ES 2053780 T3 ES2053780 T3 ES 2053780T3 ES 88400901 T ES88400901 T ES 88400901T ES 88400901 T ES88400901 T ES 88400901T ES 2053780 T3 ES2053780 T3 ES 2053780T3
Authority
ES
Spain
Prior art keywords
new
image
carbon atoms
group
dinoreburnamenine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88400901T
Other languages
English (en)
Inventor
Nurgun Aktogu
Francois Clemence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2053780T3 publication Critical patent/ES2053780T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I) EN LA QUE R1 Y R2 REPRESENTA HIDROGENO, HALOGENO,ALCOILO O ALCOXI C1-C5, HIDROXI, TRIFLUORMETILO O NITRO, R REPRESENTA HIDROGENO, ALCOILO C1-C5, ARILALCOILO C7-C12, BENZOILO O ALCOILCARBONILO Y (II) BAJO TODAS LAS FORMAS ISOMERAS POSIBLES RACEMICAS U OPTICAMENTE ACTIVAS COMO LAS SALES CON LOS ACIDOS, SU PROCEDIMIENTO DE PREPARACION, SU APLICACION A TITULO DE MEDICAMENTOS Y DE NUEVOS INTERMEDIARIOS.
ES88400901T 1987-04-15 1988-04-14 Nuevos derivados 17-aza de 20,21-dinoreburnamenina y nuevos productos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen. Expired - Lifetime ES2053780T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705361A FR2614022B1 (fr) 1987-04-15 1987-04-15 Nouveaux derives 17-aza de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et ces compositions les renfermant

Publications (1)

Publication Number Publication Date
ES2053780T3 true ES2053780T3 (es) 1994-08-01

Family

ID=9350164

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88400901T Expired - Lifetime ES2053780T3 (es) 1987-04-15 1988-04-14 Nuevos derivados 17-aza de 20,21-dinoreburnamenina y nuevos productos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen.

Country Status (10)

Country Link
US (1) US4886802A (es)
EP (1) EP0287468B1 (es)
JP (1) JPS63295576A (es)
AT (1) ATE86624T1 (es)
CA (1) CA1324793C (es)
DE (1) DE3878967T2 (es)
ES (1) ES2053780T3 (es)
FR (1) FR2614022B1 (es)
GR (1) GR3007599T3 (es)
HU (1) HU206712B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496957A (en) * 1993-09-01 1996-03-05 Virginia Commonwealth University Tryptamine analogs with 5-HT1D selectivity
FR2713644B1 (fr) * 1993-12-14 1996-02-09 Adir Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2713643B1 (fr) * 1993-12-14 1996-06-07 Adir Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5504101A (en) * 1994-05-06 1996-04-02 Allelix Biopharmaceuticals, Inc. 5-HT-1D receptor ligands
GB2296170A (en) * 1994-12-16 1996-06-19 Ibm Audio communication apparatus
DE10254596A1 (de) * 2002-11-22 2004-06-03 Merck Patent Gmbh Indolderivate
FR2926077A1 (fr) 2008-01-04 2009-07-10 Servier Lab Nouveaux derives d'1h-indol-1-yl uree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2168853B1 (es) * 1972-01-24 1975-04-25 Centre Etd Ind Pharma
US3843653A (en) * 1972-11-06 1974-10-22 Du Pont 5,6,12,13-di-isoquino-(4,3-b:4',3'-e)-pyrazine-5,12-diones

Also Published As

Publication number Publication date
EP0287468A3 (en) 1990-05-02
HU206712B (en) 1992-12-28
EP0287468A2 (fr) 1988-10-19
JPS63295576A (ja) 1988-12-01
US4886802A (en) 1989-12-12
GR3007599T3 (es) 1993-08-31
DE3878967T2 (de) 1993-08-19
CA1324793C (fr) 1993-11-30
DE3878967D1 (de) 1993-04-15
EP0287468B1 (fr) 1993-03-10
HUT46326A (en) 1988-10-28
ATE86624T1 (de) 1993-03-15
FR2614022A1 (fr) 1988-10-21
FR2614022B1 (fr) 1989-12-01

Similar Documents

Publication Publication Date Title
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
ES2053780T3 (es) Nuevos derivados 17-aza de 20,21-dinoreburnamenina y nuevos productos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen.
IL69882A (en) Analgesia-effecting 5-hydroxytryptophan derivatives and pharmaceutical compositions comprising them
AU601687B2 (en) New derivatives of carboxamide indole, their salts, process and intermediates for preparation, use as medicaments and compositions containing them
SE7704615L (sv) Sett att framstella nya 1,4-bensodioxanderivat
ES472440A1 (es) Procedimiento para fabricar derivados de 1,3-difenoxipropan -27ona.
ES524990A0 (es) Procedimiento para preparar derivados de tieno-tiazol
IL70684A (en) Bicyclo(4.2.0)1,3,5-octatriene derivatives,their preparation and pharmaceutical compositions containing them
ZA811149B (en) Cyclohepitindolol derivatives and their salts with the acids, their preparation, their use as medicaments and the compositions containing them
SE8004129L (sv) Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
DE3160621D1 (en) Triazoloquinazolinone derivatives and their acid addition salts, their preparation, their use as medicaments and compositions containing them
SE8800846L (sv) Optiskt aktiva oxo-isoindolinderivat
EP0230179A3 (en) 4-morpholinyl 1h-indole derivatives, their salts, process and intermediates of preparation, use as therapeutic agents, compositions containing them
ES2059551T3 (es) Nuevas imidazo-benzodiazepinas y sus sales de adicion con acidos, su procedimiento y los productos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen.
SE8205335D0 (sv) Nya 20,21-dinoreburnamenin-derivat, eventuellt substituerade pa e-ringen, forfarande och mellanprodukter for framstellning derav, anvendning derav sasom lekemedel samt kompositioner innehallande dem
ES8204729A1 (es) Procedimiento para la preparacion de acidos de 2-(3'-tienil)propionicos 5'-sustituidos
ES8103742A2 (es) Un procedimiento de preparacion de nuevos derivados de 1,3-benzodioxina
ES2052945T3 (es) Derivados de la 20,21-dinoreburnamenina sustituidos en 15 con un grupo aminado y sus sales, su procedimiento de preparacion y los productos intermedios asi obtenidos, su aplicacion como medicamentos, y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 287468

Country of ref document: ES